Viscadia Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Viscadia's estimated annual revenue is currently $17.7M per year.(i)
  • Viscadia's estimated revenue per employee is $201,000

Employee Data

  • Viscadia has 88 Employees.(i)
  • Viscadia grew their employee count by 40% last year.

Viscadia's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Director, Viscadia IndiaReveal Email/Phone
3
ManagerReveal Email/Phone
4
Marketing ManagerReveal Email/Phone
5
Manager, Strategic ForecastingReveal Email/Phone
6
Manager, Strategic ForecastingReveal Email/Phone
7
Manager, Strategic ForecastingReveal Email/Phone
8
ManagerReveal Email/Phone
9
Deputy ManagerReveal Email/Phone
10
Manager: Organizational Growth and DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.7M31-14%N/AN/A
#2
$7.2M366%N/AN/A
#3
$17.7M8840%N/AN/A
#4
$28.7M1435%N/AN/A
#5
$1.4M7N/AN/AN/A
#6
$15.3M761%N/AN/A
#7
$596.4M29679%N/AN/A
#8
$5.4M27-10%N/AN/A
#9
$86.8M4327%N/AN/A
#10
$5M254%N/AN/A
Add Company

What Is Viscadia?

Viscadia is the leading professional services firm focused exclusively on pharmaceutical and biotech forecasting. With decades of pharmaceutical corporate experience, we have deep expertise in forecasting, analytics, and strategy. We work with large and mid-sized pharmaceutical and biotech companies, as well as emerging specialty pharma firms. From acquisitions to pipeline candidates to on-market products, we present our domestic and global forecasts in a format that is clear and easily explainable to all stakeholders, instilling confidence and trust in the process. If you want to ensure your forecasts are comprehensive, dynamic, and clear, contact us today.

keywords:N/A

N/A

Total Funding

88

Number of Employees

$17.7M

Revenue (est)

40%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.2M887%N/A
#2
$22.4M886%N/A
#3
$7.5M880%N/A
#4
$15M886%N/A
#5
$7.5M88-7%N/A